1. Shane E. Parathyroid carcinoma. J Clin Endocrinol
Metab 2001; 86: 485-493.
2. Obara T, Fujimoto Y. Diagnosis and treatment of
patients with parathyroid carcinoma: an update and
review. World J Surg 1991; 15: 738-744.
3. Vetto JT, Brennan MF, Woodruf J, Burt M. Parathyroid
carcinoma: Diagnosis and clinical history. Surgery
1993; 114: 882-892.
4. Jackson CE, Norum RA, Boyd SB, et al. Hereditary
hyperparathyroidism and multiple ossifying jaw
fibromas: a clinically and genetically distinct syndrome.
Surgery 1990; 108: 1006-1012; discussion 1012-1013.
5. Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic
and therapeutic challenge. Cancer 1999; 86: 378-380.
6. Crescenzo DG, Shabahang M, Gravin D, Evans SR.
Intrathyroidal parathyroid cancer presenting as a left
neck mass. Thyroid 1998; 8: 597-599.
7. Cheah WK, Rauff A, Lee KO, Tan W. Parathyroid
carcinoma: A case series. Ann Acad Med Singapore
2005; 34: 443-446.
8. Koea JB, Shaw JH. Parathyroid cancer: Biology and
management. Surg Oncol 1999; 8: 155-165.
9. Thompson SD, Prichard AJ. The management of
parathyroid carcinoma. Curr Opin Otolaryngol Head
Neck Surg 2004; 12: 93-97.
10. Dionisi S, Minisola S, Pepe J, et al. Concurrent
parathyroid adenomas and carcinoma in the setting of
multiple endocrine neoplasia type 1: Presentation as
hypercalcemic crisis. Mayo Clin Proc 2002; 77: 866-869.
11. Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ. One
stage treatment of parathyroid cancer. Eur J Surg Oncol
2005; 31: 78-83.
12. Eslamy HK, Ziessman HA. Parathyroid scintigraphy in
patients with primary hyperparathyroidism: 99mTc
sestamibi SPECT and SPECT/CT. Radiographics 2008;
28: 1461-1476.
13. Lavely WC, Goetze S, Friedman KP, et al. Comparison
of SPECT/CT, SPECT, and planar imaging with
single- and dual-phase (99m)Tc-sestamibi parathyroid
scintigraphy. J Nucl Med 2007; 48: 1084-1089.
14. Civelek AC, Ozalp E, Donovan P, Udelsman R.
Prospective evaluation of delayed technetium-
99m sestamibi SPECT scintigraphy for preoperative
localization of primary hyperparathyroidism. Surgery
2002; 131: 149-157.
15. Nichols KJ, Tomas MB, Tronco GG, et al. Preoperative
parathyroid scintigraphic lesion localization: Accuracy
of various types of readings. Radiology 2008; 248:
221-232.
16. Hosking DJ, Cowley A, Bucknall CA. Rehydration in the
treatment of severe hypercalcaemia. Q J Med 1981; 50:
473-481.
17. Bilezikian JP. Management of hypercalcemia. J Clin
Endocrinol Metab 1993; 77: 1445-1449.
18. Deftos LJ, First BP. Calcitonin as a drug. Ann Intern
Med 1981; 95: 192-197.
19. Ljunghall S. Use of clodronate and calcitonin in
hypercalcemia due to malignancy. Recent results.
Cancer Res 1989; 116: 140-145.
20. Chevallier B, Peyron R, Basuyau JP, et al. Human
calcitonin in neoplastic hypercalcemia. Results of a
prospective randomized trial. Presse Med 1988; 17:
2375-2377.
21. Dumon JC, Magritte A, Body JJ. Nasal human calcitonin
for tumor-induced hypercalcemia. Calcif Tissue Int
1992; 51: 18-19.
22. Chiofalo MG, Scognamiglio F, Losito S, et al. Clinical
considerations and literature review. World J Surg
Oncol 2005; 23: 3-39.
23. Snell SB, Gaar EE, Stevens SP, Flynn MB. Parathyroid
cancer, a continued diagnostic and therapeutic
dilemma: report of four cases and review of the
literature. Am Surg 2003; 69: 711-716.
24. Tohme JF, Bilezikian JP. Hypocalcemic emergencies.
Endocrinol Metab Clin North Am 1993; 22: 363-375.
25. Shane E. Clinical review 122: Parathyroid carcinoma. J
Clin Endocrinol Metab 2002; 86: 485-493.
26. Chow E, Tsang RW, Brierley JD, Filice S. Parathyroid
carcinoma–the Princess Margaret Hospital experience.
Int J Radiat Oncol Biol Phys 1998; 41: 569-572.
27. Anderson B, Samaan N, Vassilopoulou-Sellin R,
Ordonez N, Hickey R. Parathyroid carcinoma: Features
and difficulties in diagnosis and difficulties in diagnosis
and management. Surgery 1983; 94: 906-915.
28. Hundahl SA, Fleming ID, Fremgen AM, Menck HR.
Two hundred eighty-six cases of parathyroid carcinoma
treated in the U.S. between 1985-1995: A National
Cancer Data Base Report. The American College of
Surgeons Commission on Cancer and the American
Cancer Society. Cancer 1999; 86: 538-544.
Thank you for copying data from http://www.arastirmax.com
